Detection of negative-stranded hepatitis C virus RNA using a novel strand-specific reverse transcription-polymerase chain reaction

Virus Research

Volumn 53, Issue 2, 1998, Pages 209-214

  Mizutani, Tetsuya ^a   Ikeda, Masanori ^a   Saito, Satoru ^b   Sugiyama, Kazuo ^a   Shimotohno, Kunitada ^c   Kato, Nobuyuki ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Dept Viral Oncol Inst Virus R   (Japan)

Author keywords

5' non coding region; HCV replication; Hepatitis C virus; Negative strand; Polymerase chain reaction

Indexed keywords

VIRUS RNA;

ARTICLE; HEPATITIS C VIRUS; LIVER BIOPSY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS REPLICATION;

HEPACIVIRUS; HUMANS; POLYMERASE CHAIN REACTION; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 0031908701     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00150-0     Document Type: Article

References (18)

1. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
2. Choo Q.-L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-born non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
3. Gunji T., Kato N., Hijikata M., Hayashi K., Saitoh S., Shimotohno K. Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification. Arch. Virol. 134:1994;293-302.
4. Ikeda M., Kato N., Mizutani T., Sugiyama K., Tanaka K., Shimotohno K. Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes. J. Hepatol. 27:1997;445-454.
5. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA. 87:1990;9524-9528.
6. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J. Virol. 67:1993;3923-3930.
7. Kato N., Nakazawa T., Mizutani T., Shimotohno K. Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem. Biophys. Res. Commun. 206:1995;863-869.
8. Kuo G., Choo Q.-L., Alter H.J., Gitnick G.L., Redeker A.G., Purcell R.H., Miyamura T., Dienstag J.L., Alter M.J., Stevens C.E., Tegtmeier G.E., Bonino F., Colombo W.-S., Lee W.-S., Kuo C., Berger K., Shuster J.R., Overby L.R., Bradley D.W., Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
9. Lanford R.E., Sureau C., Jacob J.R., White R., Fuerst T.R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology. 202:1994;606-614.
10. Lanford R.E., Chavez D., Chisari F.V., Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J. Virol. 69:1995;8079-8083.
11. Lerat H., Berby F., Trabaud M.-A., Vidalin O., Major M., Trepo C., Inchauspe G. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J. Clin. Invest. 97:1996;845-851.
12. Mizutani T., Kato N., Ikeda M., Sugiyama K., Shimotohno K. Long-term human T-cell culture system supporting hepatitis C virus replication. Biochem. Biophys. Res. Commun. 227:1996;822-826.
13. Novak J.E., Kirkegaard K. Improved method for detecting poliovirus negative strands used to demonstrate specificity of positive-strand encapsidation and the ratio of positive to negative strands in infected cells. J. Virol. 65:1991;3384-3387.
14. Ohkoshi S., Kojima H., Tawaraya H., Miyajima T., Kamimura T., Asakura H., Satoh A., Hirose S., Hijikata M., Kato N., Shimotohno K. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn. J. Cancer Res. 81:1990;550-553.
15. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., Choo Q.-L., Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
16. Sakamoto N., Enomoto N., Kurosaki M., Marumo F., Sato C. Detection and quantification of hepatitis C virus RNA replication in the liver. J. Hepatol. 20:1994;593-597.
17. Shimotohno K. Hepatitis C virus as a causative agent of hepatocellular carcinoma. Intervirology. 38:1995;162-169.
18. Tanaka T., Kato N., Cho M.J., Shimotohno K. A novel sequence found at the 3′ terminus of hepatitis C virus genome. Biochem. Biophys. Res. Commun. 215:1995;744-749.